Emvita 20 (RUBIMED AG)


Welcome to the PulseAid listing for the Emvita 20 drug offered from RUBIMED AG. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: RUBIMED AG
NON-PROPRIETARY NAME: STRYCHNOS IGNATII SEED, APIS MELLIFERA, PHOSPHORUS, PULSATILLA VULGARIS, and LYTTA VESICATORIA
SUBSTANCE NAME: STRYCHNOS IGNATII SEED; APIS MELLIFERA; PHOSPHORUS; PULSATILLA VULGARIS; LYTTA VESICATORIA
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00


Emvita 20 HUMAN OTC DRUG Details:

Item DescriptionEmvita 20 from RUBIMED AG
LABELER NAME: RUBIMED AG
DEA SCHEDULE:
ACTIVE STRENGTH: 16; 18; 21; 21; 21([hp_M]/mL; [hp_M]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL)
START MARKETING DATE: 2015-05-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66343-032_4d4fe0a6-a377-4ac9-bd4b-8025bf00d93d
PRODUCT NDC: 66343-032
APPLICATION NUMBER:

Other STRYCHNOS IGNATII SEED; APIS MELLIFERA; PHOSPHORUS; PULSATILLA VULGARIS; LYTTA VESICATORIA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
RUBIMED AGEmvita 20